We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$16.2B
AUM Growth
-$1.27B
(-7.2%)
Cap. Flow
-$1.42B
Cap. Flow
% of AUM
-8.75%
Top 10 Holdings %
Top 10 Hldgs %
18.5%
Holding
1,414
New
206
Increased
348
Reduced
372
Closed
450
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$456M |
| 2 |
Intel
INTC
|
+$290M |
| 3 |
Union Pacific
UNP
|
+$159M |
| 4 |
AT&T
T
|
+$143M |
| 5 |
Philip Morris
PM
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$394M |
| 2 |
AstraZeneca
AZN
|
+$307M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
TSMC
TSM
|
+$187M |
| 5 |
Canadian National Railway
CNI
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.82% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 9.75% |
| 4 | Industrials | 8.83% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRCD
101
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $40.8M | 0.25% |
3,439,379
-2,483,966
| -42% | -$29.6M |
|
102
STMicroelectronics
STM
$50B
| $39.7M | 0.24% |
4,280,785
+2,859,125
| +201% | +$24.9M |
|
103
VeriSign
VRSN
$26.6B
| $38.6M | 0.24% |
576,174
-19,949
| -3% | -$1.21M |
|
104
TransDigm Group
TDG
$67.7B
| $38.4M | 0.24% |
175,777
-18,442
| -9% | -$3.89M |
|
|
SYT
105
DELISTED
Syngenta Ag
SYT
| $37.5M | 0.23% |
553,436
+442,875
| +401% | +$29.8M |
|
106
Kimberly-Clark
KMB
$36.5B
| $37.3M | 0.23% |
+348,192
| New | +$38.5M |
|
107
Aegon
AEG
$14.1B
| $36.6M | 0.23% |
6,674,585
-1,168,736
| -15% | -$6.12M |
|
|
ABB
108
DELISTED
ABB Ltd
ABB
| $36.2M | 0.22% |
1,710,352
+1,460,012
| +583% | +$30M |
|
|
ESRX
109
DELISTED
Express Scripts Holding Company
ESRX
| $35.4M | 0.22% |
407,407
+92,296
| +29% | +$7.74M |
|
110
Sally Beauty Holdings
SBH
$1.58B
| $34.5M | 0.21% |
1,004,889
+293,753
| +41% | +$9.49M |
|
|
CERN
111
DELISTED
Cerner Corp
CERN
| $34.4M | 0.21% |
470,175
+237,439
| +102% | +$16.4M |
|
112
Jones Lang LaSalle
JLL
$16.7B
| $34.1M | 0.21% |
199,986
-645
| -0.3% | -$102K |
|
|
MJN
113
DELISTED
Mead Johnson Nutrition Company
MJN
| $33.9M | 0.21% |
337,458
+300,409
| +811% | +$30.3M |
|
114
iShares MSCI Turkey ETF
TUR
$213M
| $32.2M | 0.2% |
694,647
+611,046
| +731% | +$31.3M |
|
115
State Street SPDR S&P 500 ETF Trust
SPY
$823B
| $32.2M | 0.2% |
156,114
+12,693
| +9% | +$2.62M |
|
116
AerCap
AER
$23.8B
| $32.2M | 0.2% |
737,553
+91,104
| +14% | +$3.84M |
|
117
Boston Properties
BXP
$11.1B
| $32.2M | 0.2% |
228,907
+115,173
| +101% | +$16.1M |
|
|
CIM
118
Chimera Investment
CIM
$1B
| $31.7M | 0.2% |
673,871
-55,591
| -8% | -$2.66M |
|
119
Camden Property Trust
CPT
$11.3B
| $31.1M | 0.19% |
398,090
+66,613
| +20% | +$5.11M |
|
120
Kroger
KR
$34.8B
| $30.9M | 0.19% |
+804,968
| New | +$28.7M |
|
121
iShares MSCI Taiwan ETF
EWT
$10.7B
| $30.8M | 0.19% |
978,976
-143,489
| -13% | -$4.48M |
|
122
Domino's
DPZ
$11.6B
| $30.4M | 0.19% |
302,711
+262,444
| +652% | +$26.4M |
|
123
Bath & Body Works
BBWI
$4.1B
| $30.3M | 0.19% |
398,152
+393,683
| +8,809% | +$28.4M |
|
124
Galicia Financial Group
GGAL
$7.42B
| $30.2M | 0.19% |
1,303,582
| – | – |
|
125
Community Health Systems
CYH
$423M
| $29.7M | 0.18% |
687,063
+175,719
| +34% | +$7.28M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Arrowstreet Capital held 1,414 positions worth $16.2B, down 7.2% from $17.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $1.42B in Q1 2015, closing 450 positions and reducing 372 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $394M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Arrowstreet Capital opened a new position in Apple worth $470M.
- Arrowstreet Capital's largest Q1 2015 buy was Apple: 15,110,160 shares worth $470M.
- Arrowstreet Capital added most to Intel in Q1 2015, an estimated $290M increase.
- Arrowstreet Capital's biggest Q1 2015 reduction was AstraZeneca, cutting an estimated $307M.
- Arrowstreet Capital fully exited Teva Pharmaceuticals in Q1 2015, selling an estimated $394M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $16.2B portfolio in Q1 2015.
- Arrowstreet Capital opened 206 new positions and closed 450 in Q1 2015.
- Arrowstreet Capital's portfolio value fell 7.2% quarter-over-quarter to $16.2B.
Based on Arrowstreet Capital's 13F filing for Q1 2015, filed 15 May 2015.